Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 9701–9750 of 34760
On May 8, 2024, the Board of Directors of Tronox Holdings plc (the “Company”) appointed Mrs. Lucrece Foufopoulos-De Ridder as an independent Director.
Effective June 4, 2024, the Board of Directors (the “Board”) of Vontier Corporation (the “Company”) approved an increase in the size of the Board from nine to ten members and appointed Mr. James Darrell Thomas to the Board as a Class II director.
On May 6, 2024, the Company accepted the resignation of Dallas Hack as a member of the Board effective as of May 6, 2024.
On April 24, 2024, Applied UV, Inc. (the “Company”) accepted the resignation of Brian Stern as a member of the Board of Directors of the Company (“Board”) effective as of April 24, 2024.
On April 25, 2024, Livio Susin, a member of the Board of Directors of the Company, resigned, effective immediately.
On May 8, 2024, Mr. Confer was also appointed to the Board as a Class III director to fill the vacancy caused by Mr. Varner’s passing
On May 2, 2024, we appointed Ryan E. Holland to our Board of Directors for a three (3) year term.
On May 6, 2024, Jeffery Jordan, an independent member of the board of directors (the “Board”) of Pinterest, Inc. (the “Company”) notified the Board of his decision to retire from the Board effective May 9, 2024.
On May 8, 2024, Charles “Chip” Bergh was appointed to the Company’s Board effective May 9, 2024 as a Class I director.
Paul Funk, II (3) Chair, Nominating and Governance Committee
Dr. Schwartz resigned as a director of the Company effective as of May 7, 2024
On May 8, 2024, following a search process, the Board of Directors (the “Board”) of the Company appointed Cynthia Williams as the Company’s Chief Executive Officer and a Class II director, in each case effective May 20, 2024 (the “Effective Date”).
Andrew Perlmutter resigned as a Class II director of the Company, effective on the Effective Date.
On May 9, 2024, Western New England Bancorp, Inc. (the “Company” or “WNEB”) (NasdaqGS: WNEB), the holding company for Westfield Bank (the “Bank”) accepted the retirement of Gregg F. Orlen from its Board of Directors.
On May 7, 2024, the Board of Directors of Emerson Electric Co. (the “Company”) elected Calvin G. Butler, Jr. as a Director of the Company, effective as of August 1, 2024 (the “Effective Date”).
On May 3, 2024, the Nominating and Corporate Governance Committee (the “ Committee ”) of the Board of Directors (the “ Board ”) of SAB Biotherapeutics, Inc., a Delaware corporation (the “ Company ”), recommended the appointment of, and the Board subsequently appointed, Dr. Jay S. Skyler to serve as a Class I director of the Company, effective as of May 3, 2024, and to serve until the Company’s 2025 annual meeting of stockholders or until Dr. Skyler’s successor is duly elected and qualified.
the Board appointed George Riedel to the Board as a Class II director
On May 5, 2024, the board of directors (the “Board”) of QMIS TBS Capital Group Corp., a Delaware corporation (the “Company”) , appointed four additional members of the Board: Dr. Hj Mazlan Bin Ahmad; Lee Chang Yee; Wei Chen, Jerry; and Lim Bing Khim, effective as of that date.
On May 5, 2024, the board of directors (the “Board”) of QMIS TBS Capital Group Corp., a Delaware corporation (the “Company”) , appointed four additional members of the Board: Dr. Hj Mazlan Bin Ahmad; Lee Chang Yee; Wei Chen, Jerry; and Lim Bing Khim, effective as of that date.
On May 5, 2024, the board of directors (the “Board”) of QMIS TBS Capital Group Corp., a Delaware corporation (the “Company”) , appointed four additional members of the Board: Dr. Hj Mazlan Bin Ahmad; Lee Chang Yee; Wei Chen, Jerry; and Lim Bing Khim, effective as of that date.
On May 5, 2024, the board of directors (the “Board”) of QMIS TBS Capital Group Corp., a Delaware corporation (the “Company”) , appointed four additional members of the Board: Dr. Hj Mazlan Bin Ahmad; Lee Chang Yee; Wei Chen, Jerry; and Lim Bing Khim, effective as of that date.
The Company today announced that John F. Kelly, former Vice President Quality Operations and Environment, Health & Safety at Pfizer Inc. was elected to the Company’s Board of Directors on May 7, 2024.
Effective May 8, 2024, Mr. Xingjia Gao resigned as a Director from the Board of the Company, due to personal reasons.
on May 3, 2024, Rolf Classon notified Masimo’s Board of Directors (the “Board”) of Mr. Classon’s decision to resign from the Board and the Audit Committee of the Board (the “Audit Committee”), effective as of May 10, 2024.
On May 6, 2024, Joseph Gitto, a member of the board of directors (the “Board”) of iCoreConnect Inc. (the “Company”) resigned from his position as member of the Board.
Laela Sturdy notified the Company of her resignation from the Company’s Board of Directors, including its Audit Committee and its Mergers and Acquisition Committee, effective as of such date.
On May 6, 2024, Patricia H. Roberts tendered her resignation as a director of the Company, with effect from May 15, 2024.
On May 7, 2024, Rachelle Jacques resigned from the Board of Directors (the “Board”), effective May 7, 2024.
On May 6, 2024, the Board of Directors (the “Board”) of Edgewise Therapeutics, Inc. (the “Company”) appointed Arlene Morris to serve (i) as a Class I director, with a term expiring at the Company’s 2025 annual meeting of stockholders, (ii) as a member of the Audit Committee of the Board (the “Audit Committee”), and (iii) as a member of the Compensation Committee of the Board (the “Compensation Committee”), replacing Peter Thompson as a member of the Audit Committee and Compensation Committee.
the board of directors of the Company (the “Board”) appointed Jose Segrera to the Company’s Board to fill the vacancy resulting from the resignation of Mr. McMillin, effective May 17, 2024.
the Board increased the number of directors of the Board to ten members and accelerated the effective date of Mr. Segrera's service to May 5, 2024.
On May 7, 2024, the board of directors of Midland States Bancorp, Inc. (the “Company”), the holding company of Midland States Bank (the “Bank”), appointed Travis J. Franklin as a director of the Company.
On May 1, 2024, the Board of Directors (the “Board”) of Equifax Inc. (the “Company”) appointed Barbara A. Larson as an independent director, to serve a term expiring at the Company’s 2025 Annual Meeting of Shareholders.
Pursuant to the Plan, John Doerr and Ryan Panchadsaram became directors of Reorganized Amyris.
Pursuant to the Plan, John Doerr and Ryan Panchadsaram became directors of Reorganized Amyris.
On May 3, 2024, Terri A. Herubin notified the Company of her resignation from the Company’s Board of Trustees (the “Board”), effective May 31, 2024.
appointed Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. as directors.
appointed Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. as directors.
Isan Chen, M.D. resigned from the Board and the Compensation Committee of the Board effective as of May 7, 2024.
On May 1, 2024, the Board of Directors (the “Board”) of the Company appointed Teresa Gallo, the Company’s CEO, Bruce Cooperman, Michael Garone and Paul Richardson as Directors of the Company.
On May 1, 2024, the Board of Directors (the “Board”) of the Company appointed Teresa Gallo, the Company’s CEO, Bruce Cooperman, Michael Garone and Paul Richardson as Directors of the Company.
On May 1, 2024, the Board of Directors (the “Board”) of the Company appointed Teresa Gallo, the Company’s CEO, Bruce Cooperman, Michael Garone and Paul Richardson as Directors of the Company.
On May 1, 2024, the Board of Directors (the “Board”) of the Company appointed Teresa Gallo, the Company’s CEO, Bruce Cooperman, Michael Garone and Paul Richardson as Directors of the Company.
Effective May 3, 2024, Dr. Richard J. Goldberg was appointed to the Company’s Board of Directors.
On May 1, 2024, the Company received an email from Peter N. Christos stating that, strictly for personal reasons, he was resigning from the Company’s Board of Directors.
On May 1, 2024, Christine Wang, a current Class I director of LegalZoom’s Board of Directors (the “Board”), resigned as a member of the Board, effective the same day.
On May 3, 2024, the board of directors of BioSig Technologies, Inc. (the “Board”) appointed Messrs. Steven E. Abelman and Donald F. Browne as directors on the Board.
On May 3, 2024, the board of directors of BioSig Technologies, Inc. (the “Board”) appointed Messrs. Steven E. Abelman and Donald F. Browne as directors on the Board.
As previously announced on May 2, 2024, the Board appointed Mr. Chris Baer as a director on the Board.
Effective May 6, 2024, the board of directors of the Company appointed Dennis Matheis as a Class A director of the Company.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.